Current  	Current  	 JJ	B-NP
indications  	indications  	 NNS	I-NP
for  	for  	 IN	O
prevention  	prevention  	 NN	O
and  	and  	 CC	O
therapy  	therapy  	 NN	O
of  	of  	 IN	O
steroid-induced  	steroid-induced  	 JJ	O
osteoporosis  	osteoporosis  	 NN	B-NP
in  	in  	 IN	O
men  	men  	 NNS	O
and  	and  	 CC	O
women  	women  	 NNS	O
Steroid-induced  	Steroid-induced  	 JJ	O
osteoporosis  	osteoporosis  	 NN	B-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
textbook  	textbook  	 JJ	B-NP
example  	example  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
secondary  	secondary  	 JJ	I-NP
type  	type  	 NN	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
medical  	medical  	 JJ	B-NP
condition 	condition 	 NN	I-NP
.  	.  	 .	O
Glucocorticosteroids  	Glucocorticosteroids  	 JJ	O
suppress  	suppress  	 JJ	O
bone  	bone  	 NN	O
formation  	formation  	 NN	O
by  	by  	 IN	O
their  	their  	 PRP$	O
direct  	direct  	 JJ	O
and  	and  	 CC	O
indirect  	indirect  	 JJ	O
effect  	effect  	 NN	O
on  	on  	 IN	O
osteoblasts 	osteoblasts 	 NN	B-NP
,  	,  	 ,	O
osteoclasts  	osteoclasts  	 NN	B-NP
and  	and  	 CC	O
osteocytes 	osteocytes 	 NN	B-NP
,  	,  	 ,	O
increasing  	increasing  	 VBG	O
their  	their  	 PRP$	O
resorption  	resorption  	 NN	B-NP
and 	and 	 CC	O
,  	,  	 ,	O
eventually 	eventually 	 RB	O
,  	,  	 ,	O
leading  	leading  	 VBG	O
to  	to  	 TO	O
negative  	negative  	 JJ	B-NP
bone  	bone  	 NN	I-NP
balance 	balance 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
clinical  	clinical  	 JJ	B-NP
problem  	problem  	 NN	I-NP
arises  	arises  	 VBZ	O
regarding  	regarding  	 VBG	O
the  	the  	 DT	O
fact  	fact  	 NN	O
that  	that  	 WDT	O
approximately  	approximately  	 RB	O
50 	50 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
on  	on  	 IN	O
chronic  	chronic  	 FW	B-NP
steroid  	steroid  	 FW	I-NP
therapy  	therapy  	 FW	I-NP
undergo  	undergo  	 FW	O
asymptomatic  	asymptomatic  	 FW	B-NP
bone  	bone  	 FW	I-NP
fractures 	fractures 	 FW	I-NP
.  	.  	 .	O
The  	The  	 DT	O
treatment  	treatment  	 NN	B-NP
mode  	mode  	 NN	I-NP
includes  	includes  	 VBZ	O
minimising  	minimising  	 VBG	O
the  	the  	 DT	O
dose  	dose  	 NN	O
of  	of  	 IN	O
administered  	administered  	 JJ	O
steroids 	steroids 	 NNS	O
,  	,  	 ,	O
encouraging  	encouraging  	 VBG	O
an  	an  	 DT	O
improved  	improved  	 JJ	O
lifestyle  	lifestyle  	 NN	O
and  	and  	 CC	O
supplementation  	supplementation  	 NN	B-NP
with  	with  	 IN	O
adequate  	adequate  	 JJ	O
calcium  	calcium  	 NN	B-NP
and  	and  	 CC	O
vitamin  	vitamin  	 JJ	B-NP
D 	D 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
3 	3 	 LS	I-NP
)  	)  	 -RRB-	I-NP
doses 	doses 	 NNS	I-NP
.  	.  	 .	O
Bisphosphonates  	Bisphosphonates  	 NNS	B-NP
are  	are  	 VBP	O
a  	a  	 DT	O
group  	group  	 NN	O
of  	of  	 IN	O
medical  	medical  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
used  	used  	 VBD	O
both  	both  	 DT	O
to  	to  	 TO	O
prevent  	prevent  	 VB	O
and  	and  	 CC	O
treat  	treat  	 VB	O
steroid-induced  	steroid-induced  	 JJ	O
osteoporosis 	osteoporosis 	 NN	B-NP
,  	,  	 ,	O
although  	although  	 IN	O
new  	new  	 JJ	O
therapies  	therapies  	 NNS	O
have  	have  	 VBP	O
also  	also  	 RB	O
become  	become  	 VB	O
available  	available  	 JJ	O
in  	in  	 IN	O
recent  	recent  	 JJ	O
years 	years 	 NNS	O
.  	.  	 .	O
